AP NEWS
This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Globe Newswire
This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation.

Zai Lab to Present at the 8th Annual SVB Leerink Global Healthcare Conference

February 20, 2019

SHANGHAI, China, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced that Tao Fu, President and Chief Operating Officer, will present at the 8th Annual SVB Leerink Global Healthcare Conference on Thursday, February 28, 2019 at 1:30 p.m. EST. The conference will be held in New York, NY.

Individuals may access a live webcast of the Conference presentation on the Zai Lab website at www.zailaboratory.com under “Events & Presentations” in the “Investors” section. A replay of the webcast will be available on this site for 90 days following the live event.

About Zai LabZai Lab (NASDAQ: ZLAB) is a China and US-based innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Zai Lab’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast-growing segments of China’s pharmaceutical market and addressing unmet medical needs. Zai Lab’s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partners’ and its own products in order to impact human health worldwide.

Contact:

Zai LabBilly Cho, CFO+86 137 6151 2501 billy.cho@zailaboratory.com

Media: Nancie Steinberg / Robert FlammBurns McClellan, on behalf of Zai Lab212-213-0006, ext. 318 / 364, nsteinberg@burnsmc.com / rflamm@burnsmc.com

Investors: Jill SteierBurns McClellan, on behalf of Zai Lab212-213-0006, ext. 367, jsteier@burnsmc.com